WeVote
Log In

Bill

Bill

SB 320

AN ACT TO AMEND TITLE 16 AND TITLE 24 OF THE DELAWARE CODE RELATING TO PHARMACY AND PHARMACISTS.

153rd General Assembly (2025-2026) Introduced by Frank Cooke and 7 co-sponsors

SB 320 updates Delaware pharmacy regulations to expand pharmacist services, clarify licensure and practice standards, and strengthen patient safety and access.

Passed By House. Votes: 27 YES 12 NO 2 ABSENT
0
WeVote Research Nonpartisan
Bill Summary · SB 320

Summary of SB 320 (Session 153, Delaware)

Purpose and intent

  • SB 320 proposes amendments to Title 16 and Title 24 of the Delaware Code to address matters related to pharmacy and pharmacists.
  • The bill is introduced with the aim of updating or clarifying regulatory and professional standards for pharmaceutical practice within the state.

Key provisions and changes (subject to text of the bill)

Note: The following highlights cover typical areas such bills address. For precise language, consult the bill text when available.

  • Pharmacy practice standards

    • Potential updates to licensure requirements, scope of practice for pharmacists, and standards of professional conduct.
    • Possible alignment with national guidelines or recent state regulatory updates to reflect evolving pharmacy roles (e.g., immunization authority, patient care services, and collaborative practice provisions).

  • Pharmacist responsibilities and patient access

    • Possible expansion or specification of pharmacist-provided services (e.g., vaccination administration, point-of-care testing, therapy management) and related recordkeeping or reporting requirements.
    • Clarifications on pharmacist authority to dispense medications under certain conditions or through pharmacy networks.

  • Licensing and regulation themes

    • Updates to licensure renewal processes, continuing education requirements, or disciplinary procedures.
    • Provisions related to pharmacist employment settings (e.g., community pharmacies, hospitals, and long-term care facilities) and compliance with state boards.

  • Consumer protection and safety

    • Provisions to enhance patient safety, medication management, and error reporting.
    • Requirements for pharmacies to maintain certain standards of operation, storage, and record accuracy.

  • Interplay with Title 16 and Title 24

    • Amendments to cross-reference regulations, professional standards, and oversight mechanisms overseen by relevant state boards or commissions.

Who would be affected

  • Pharmacists licensed to practice in Delaware.
  • Pharmacy professionals and technicians under the oversight of the Delaware Board of Pharmacy or equivalent regulatory body.
  • Pharmacists and pharmacy entities (retail, hospital, long-term care, and mail-order) subject to state pharmacy practice standards.
  • Patients and consumers who receive pharmaceutical services in Delaware, including immunizations and disease management services performed by pharmacists.

Procedural and timeline aspects

  • Status: Introduced and assigned to the Health & Social Services Committee in the Delaware Senate on May 14, 2026.
  • Next steps typically include committee analysis, potential public hearings, amendments, and eventually floor votes in the Senate and then the House before reaching the governor for signature.
  • Committee consideration will determine whether the bill advances, is amended, or is tabled.

Additional notes

  • Co-sponsors include Senator Trey Paradee and Senators Spiros Mantzavinos, Eric Morrison, Ray Seigfried, and Marie Pinkney, indicating bipartisan or cross-senatorial interest in pharmacy-related reform.
  • Because the bill’s full text and specific section-by-section language are not provided here, readers should review the bill text for exact amendments, definitions, effective dates, and any sunset provisions or transition periods.

If you’d like, I can refine this summary once the bill’s full text is available, or tailor it to a particular stakeholder (e.g., patients, pharmacists, or pharmacy employers).

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.